Prevalence and prognosis of fulminant type 1 diabetes mellitus in The Middle East: a comparative analysis in a 5-year nationwide cohort.

"Declarations Ethics approval and consent to participateThis work is original, has not been, and is not under consideration for publication in any other Journal. The study was conducted in full compliance with the principles of the “Declaration of Helsinki,” Good Clinical Practice (GCP), and other relevant guidelines. The study protocol was approved by the institutional review board (IRB) of the Medical Research Center (MRC) Qatar (MRC-01-21-698). The IRB at the Medical Research Center (MRC), Hamad Medical Corporation, Qatar, waived the need for informed consent, considering the retrospective nature of data review. Consent for publicationNot applicable. Competing interestsThe authors declare no conflicts of interest. Competing interests The authors declare no conflicts of interest."

"Funding This study was not funded. However, Article processing charges are covered by Qatar National Library."